Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying

Lumen Technologies和其他两只低于2美元的股票内部人士正在买入

Benzinga · 03/06 06:56

The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Aclaris Therapeutics

The Trade: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Andrew Kenneth William Powell acquired a total of 14,500 shares an average price of $1.24. To acquire these shares, it cost around $17,955.
What's Happening: Aclaris Therapeutics reported its fourth-quarter earnings results on Feb. 27, 2024.
What Aclaris Therapeutics Does: Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases.

Lumen Technologies

The Trade: Lumen Technologies, Inc. (NASDAQ:LUMN) Director Laurie Siegel acquired a total of 30,000 shares at at an average price of $1.60. To acquire these shares, it cost around $47,997.
What's Happening: On March 1, Lumen Technologies named Ryan Asdourian as its new Executive Vice President and Chief Marketing Officer.
What Lumen Technologies Does: With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises.

Personalis

The Trade: Personalis, Inc. (NASDAQ:PSNL) Director Woodrow A Myers Jr acquired a total of 10,000 shares at an average price of $1.67. The insider spent around $16,700 to buy those shares.
What's Happening: On Feb. 28, Personalis posted downbeat quarterly results.
What Personalis Does: Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.

Don't forget to check out our premarket coverage here

The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道琼斯指数周二收盘下跌400多点。当内部人士购买或出售股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将此视为他们整体投资或交易决策的一个因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。

Aclaris Therapeutics

Aclaris Therape

The Trade: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Andrew Kenneth William Powell acquired a total of 14,500 shares an average price of $1.24. To acquire these shares, it cost around $17,955.
What's Happening: Aclaris Therapeutics reported its fourth-quarter earnings results on Feb. 27, 2024.
What Aclaris Therapeutics Does: Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases.

交易：Aclaris Therapeutics, Inc.（纳斯达克股票代码：ACRS）董事安德鲁·肯尼思·威廉·鲍威尔 共收购了 14,500 股股票 平均价格为1.24美元。收购这些股票的成本约为17,955美元。
发生了什么：Aclaris Therapeutics于2024年2月27日公布了其第四季度财报。
Aclaris Therapeutics的所作所为：Aclaris Therapeutics Inc是一家临床阶段的生物制药公司，在美国运营。它专注于开发免疫炎症性疾病的新型候选药物。

Lumen Technologies

流明科技

The Trade: Lumen Technologies, Inc. (NASDAQ:LUMN) Director Laurie Siegel acquired a total of 30,000 shares at at an average price of $1.60. To acquire these shares, it cost around $47,997.
What's Happening: On March 1, Lumen Technologies named Ryan Asdourian as its new Executive Vice President and Chief Marketing Officer.
What Lumen Technologies Does: With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises.

交易：Lumen Technologies, Inc.（纳斯达克股票代码：LUMN）董事劳里·西格尔 共收购了 30,000 股股票 平均价格为1.60美元。收购这些股票的成本约为47,997美元。
发生了什么：3月1日，Lumen Technologies任命瑞安·阿斯杜里安为新任执行副总裁兼首席营销官。
Lumen Technologies的业务：Lumen Technologies拥有45万英里的光纤，是美国最大的电信运营商之一，为全球企业提供服务。

Personalis

个人主义

The Trade: Personalis, Inc. (NASDAQ:PSNL) Director Woodrow A Myers Jr acquired a total of 10,000 shares at an average price of $1.67. The insider spent around $16,700 to buy those shares.
What's Happening: On Feb. 28, Personalis posted downbeat quarterly results.
What Personalis Does: Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.

贸易：Personalis, Inc.（纳斯达克股票代码：PSNL）董事小伍德罗·迈尔斯 共收购了 10,000 股股票 平均价格为1.67美元。知情人士花费了约16,700美元购买了这些股票。
发生了什么：2月28日，Personalis公布了悲观的季度业绩。
Personalis做什么：Personalis Inc是基因组测序和分析解决方案的提供商，以支持个性化癌症疫苗和其他下一代癌症免疫疗法的开发。

Don't forget to check out our premarket coverage here

别忘了在这里查看我们的上市前报道

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息